Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Treatment of N-methyl-D-aspartate (NMDA) Enhancers for Schizophrenia

This study has been completed.
Sponsor:
Collaborator:
China Medical University Hospital
Information provided by (Responsible Party):
Chun Yuan Lin , MD, Chang-Hua Hospital
ClinicalTrials.gov Identifier:
NCT01047592
First received: January 12, 2010
Last updated: July 6, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)